These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 19488929)

  • 1. Acid and bile salt up-regulate BMP4 expression in human esophageal epithelium cells.
    Zhou G; Sun YG; Wang HB; Wang WQ; Wang XW; Fang DC
    Scand J Gastroenterol; 2009; 44(8):926-32. PubMed ID: 19488929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone morphogenetic protein 4 expressed in esophagitis induces a columnar phenotype in esophageal squamous cells.
    Milano F; van Baal JW; Buttar NS; Rygiel AM; de Kort F; DeMars CJ; Rosmolen WD; Bergman JJ; VAn Marle J; Wang KK; Peppelenbosch MP; Krishnadath KK
    Gastroenterology; 2007 Jun; 132(7):2412-21. PubMed ID: 17570215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BMP4 promotes a phenotype change of an esophageal squamous epithelium via up-regulation of KLF4.
    Yan W; Zhang H; Li J; Shen C; Xia Y; Wang P; Zhang Y; Feng J; Shao S; Yu X; Fang D
    Exp Mol Pathol; 2016 Oct; 101(2):259-266. PubMed ID: 27693253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sox9 drives columnar differentiation of esophageal squamous epithelium: a possible role in the pathogenesis of Barrett's esophagus.
    Clemons NJ; Wang DH; Croagh D; Tikoo A; Fennell CM; Murone C; Scott AM; Watkins DN; Phillips WA
    Am J Physiol Gastrointest Liver Physiol; 2012 Dec; 303(12):G1335-46. PubMed ID: 23064761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile acid-induced expression of activation-induced cytidine deaminase during the development of Barrett's oesophageal adenocarcinoma.
    Morita S; Matsumoto Y; Okuyama S; Ono K; Kitamura Y; Tomori A; Oyama T; Amano Y; Kinoshita Y; Chiba T; Marusawa H
    Carcinogenesis; 2011 Nov; 32(11):1706-12. PubMed ID: 21890457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
    O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
    Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the bile acid receptor FXR in Barrett's esophagus and enhancement of apoptosis by guggulsterone in vitro.
    De Gottardi A; Dumonceau JM; Bruttin F; Vonlaufen A; Morard I; Spahr L; Rubbia-Brandt L; Frossard JL; Dinjens WN; Rabinovitch PS; Hadengue A
    Mol Cancer; 2006 Oct; 5():48. PubMed ID: 17054793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BMP4 Signaling Is Able to Induce an Epithelial-Mesenchymal Transition-Like Phenotype in Barrett's Esophagus and Esophageal Adenocarcinoma through Induction of SNAIL2.
    Kestens C; Siersema PD; Offerhaus GJ; van Baal JW
    PLoS One; 2016; 11(5):e0155754. PubMed ID: 27191723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of bile acids in the neoplastic progression of Barrett's esophagus - a short representative overview.
    Jürgens S; Meyer F; Spechler SJ; Souza R
    Z Gastroenterol; 2012 Sep; 50(9):1028-34. PubMed ID: 22965634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the interleukin-6/STAT3 antiapoptotic pathway in esophageal cells by bile acids and low pH: relevance to barrett's esophagus.
    Dvorak K; Chavarria M; Payne CM; Ramsey L; Crowley-Weber C; Dvorakova B; Dvorak B; Bernstein H; Holubec H; Sampliner RE; Bernstein C; Prasad A; Green SB; Garewal H
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5305-13. PubMed ID: 17875759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile salt exposure increases proliferation through p38 and ERK MAPK pathways in a non-neoplastic Barrett's cell line.
    Jaiswal K; Lopez-Guzman C; Souza RF; Spechler SJ; Sarosi GA
    Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G335-42. PubMed ID: 16239404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatty acid synthase expression in Barrett's esophagus: implications for carcinogenesis.
    Ishimura N; Amano Y; Sanchez-Siles AA; Fukuhara H; Takahashi Y; Uno G; Tamagawa Y; Mishima Y; Yuki T; Ishihara S; Kinoshita Y
    J Clin Gastroenterol; 2011 Sep; 45(8):665-72. PubMed ID: 21325951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel findings in the pathogenesis of esophageal columnar metaplasia or Barrett's esophagus.
    Krishnadath KK
    Curr Opin Gastroenterol; 2007 Jul; 23(4):440-5. PubMed ID: 17545783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of BMP2 and BMP4 Represses Barrett's Esophagus While Enhancing the Regeneration of Squamous Epithelium in Preclinical Models.
    Correia ACP; Straub D; Read M; Hoefnagel SJM; Romero-Pinedo S; Abadía-Molina AC; Clemons NJ; Wang K; Calpe S; Phillips W; Krishnadath KK
    Cell Mol Gastroenterol Hepatol; 2023; 15(5):1199-1217. PubMed ID: 36706916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase-2 (COX-2) is the key event in pathophysiology of Barrett's esophagus. Lesson from experimental animal model and human subjects.
    Majka J; Rembiasz K; Migaczewski M; Budzynski A; Ptak-Belowska A; Pabianczyk R; Urbanczyk K; Zub-Pokrowiecka A; Matlok M; Brzozowski T
    J Physiol Pharmacol; 2010 Aug; 61(4):409-18. PubMed ID: 20814068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the BMP4 pathway and early expression of CDX2 characterize non-specialized columnar metaplasia in a human model of Barrett's esophagus.
    Castillo D; Puig S; Iglesias M; Seoane A; de Bolós C; Munitiz V; Parrilla P; Comerma L; Poulsom R; Krishnadath KK; Grande L; Pera M
    J Gastrointest Surg; 2012 Feb; 16(2):227-37; discussion 237. PubMed ID: 22076569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specialized metaplastic columnar epithelium in Barrett's esophagus. A comparative transmission electron microscopic study.
    Levine DS; Rubin CE; Reid BJ; Haggitt RC
    Lab Invest; 1989 Mar; 60(3):418-32. PubMed ID: 2927081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bile acid-stimulated expression of the farnesoid X receptor enhances the immune response in Barrett esophagus.
    Capello A; Moons LM; Van de Winkel A; Siersema PD; van Dekken H; Kuipers EJ; Kusters JG
    Am J Gastroenterol; 2008 Jun; 103(6):1510-6. PubMed ID: 18510604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abundant expression of the intestinal protein villin in Barrett's metaplasia and esophageal adenocarcinomas.
    Regalado SP; Nambu Y; Iannettoni MD; Orringer MB; Beer DG
    Mol Carcinog; 1998 Jul; 22(3):182-9. PubMed ID: 9688144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced expression of decay-accelerating factor, a complement-regulatory protein, in the specialized intestinal metaplasia of Barrett's esophagus.
    Hiraoka S; Mizuno M; Nasu J; Okazaki H; Makidono C; Okada H; Terada R; Yamamoto K; Fujita T; Shiratori Y
    J Lab Clin Med; 2004 Apr; 143(4):201-6. PubMed ID: 15085078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.